{
    "id": "5c915e51ecadf2e73f00000c",
    "question": "Can prevnar 13 be used in children?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to consider the safety and efficacy of Prevnar 13 (Pneumococcal conjugate vaccine, PCV13) in children. Prevnar 13 is a vaccine that protects against 13 serotypes of pneumococcal disease, including Streptococcus pneumoniae, Haemophilus influenzae type b (Hib), and meningococcus group C, Y, and W. Prevnar 13 is approved for use in children as young as 2 months of age, and it is recommended as part of the routine vaccination schedule in many countries. The Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics (AAP) recommend that all children receive PCV13 as part of their vaccination schedule. In general, children under 2 years of age are at higher risk of developing pneumococcal disease, and vaccination with Prevnar 13 can help protect them from serious infections such as pneumonia, meningitis, and sepsis. Therefore, based on the available evidence and recommendations from reputable health organizations, Prevnar 13 can be used in children.\", \"answer_choice\": \"A\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 24.6612765789032
}